TrialJournal of Alzheimer's disease : JAD2017

Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.

Victor Bloniecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.